The British government signs an agreement to secure 480,000 courses of Molnupiravir produced by Merck Sharp and Dohme, and 250,000 courses of Ritonavir produced by Pfizer, where both of them need to be approved by health regulator.
The British government signs a agreement to secure 480,000 courses of Molnupiravir produced by Merck Sharp and Dohme, and 250,000 courses of Ritonavir produced by Pfizer, where both of them need to be approved by health regulator.
The British government signs an agreement to secure 480,000 courses of Molnupiravir produced by Merck Sharp and Dohme, and 250,000 courses of Ritonavir produced by Pfizer, where both of them need to be approved by health regulator.